Press Releases NeoGenomics, Inc.

Equities

NEO

US64049M2098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
14.14 ^USD	+2.09%		+4.51%	-12.61%

Apr. 18	NeoGenomics, Inc. Announces Senior Leadership Promotions	CI
Apr. 18	NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeoGenomics Announces Senior Leadership Promotions	Apr. 18	BU
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024	Apr. 09	BU
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting	Mar. 27	BU
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report	Mar. 20	BU
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	Mar. 04	AQ
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	Mar. 01	BU
NeoGenomics: Q4 Earnings Snapshot	Feb. 20	AQ
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results	Feb. 20	BU
NeoGenomics Signs Working with Cancer Pledge in Support of Employees	Feb. 01	BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO	Jan. 30	PR
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024	Jan. 30	BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO	Jan. 22	PR
Natera And The Power Of The Patent	Jan. 17	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO	Jan. 14	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO	Jan. 06	PR
ROSEN, A LEADING NATIONAL FIRM, Encourages NeoGenomics, Inc. Investors to Inquire About Securities Class Action Investigation – NEO	Jan. 02	BU
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO	Dec. 29	PR
Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall, Thursday, 12/28/2023	Dec. 28	AQ
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response	Dec. 06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NeoGenomics, Inc.

Equities

NEO

US64049M2098

Press Releases

Filters